Anviro Therapeutics (Anviro) is a broad-spectrum antiviral company that is developing treatments for some of the world’s most problematic infectious diseases, including pox viruses and herpes viruses. Our lead program is based on technology discovered by researchers at Brigham Young University (BYU). This compound, designated KPB-100, was found to have powerful antiviral properties, and efficacy across a wide range of viruses in the herpes and pox virus families. In April of 2015, Anviro licensed this technology from BYU and are in the process of medicinal optimization and animal model validation. Please visit us at AnviroTherapeutics.com for more information.
Company Details
- Founded
- -
- Address
- 1372 S 740 E, Orem,utah 84097,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://AnviroTherapeutics.com
- Keywords
- Drug Development, Translational Research, Life Sciences, Antiviral, Antiherpes, Herpesvirus, Herpes, Orthopox, Orthopoxvirus, Small Pox, Vaccinia, Biotech, Pharmaceutical Development, Pharmaceuticals.
- HQ
- Orem, Utah
Anviro Therapeutics Questions
Anviro Therapeutics's website is http://AnviroTherapeutics.com
Anviro Therapeutics's LinkedIn profile is https://www.linkedin.com/company/anviro-therapeutics
Anviro Therapeutics's industry is
Pharmaceutical Manufacturing
Anviro Therapeutics's top competitors are
Elbardy For Export,
Femicare,
Sanus Solutions Llc,
Candel Therapeutics,
Heidelberg Immunotherapeutics Gmbh.
Anviro Therapeutics's categories are Pharmaceutical Manufacturing
Anviro Therapeutics's founding year is 2015
